Product Details

Vercef-400 Capsules meet Indian Pharmacopoeia (IP) standards for the treatment of bacterial infections. Specifically, each capsule delivers Cefixime IP at 400mg. As a result, it offers broad-spectrum, third-generation cephalosporin coverage for a range of common bacterial infections.

The capsules contain:

• Cefixime IP (400mg) – A third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Consequently, it exerts bactericidal activity against a broad range of gram-positive and gram-negative organisms, including many resistant to earlier-generation antibiotics.

Physicians prescribe Vercef-400 for the treatment of susceptible bacterial infections, including respiratory tract infections, urinary tract infections, and ear, nose, and throat infections. In addition, its once-daily or twice-daily oral dosing supports simple, convenient treatment courses. Because of this profile, Vercef-400 suits general practice, paediatric, and hospital settings where reliable broad-spectrum antibacterial therapy is needed.

Key Features:

• Overall, this IP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the oral capsule format supports easy, convenient dosing
• Furthermore, each capsule delivers precise, validated dosage accuracy at 400mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, blister packaging protects capsule integrity against light and moisture
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies